Drugs / MK0354
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00337415 | May → Aug 2006 | hyperlipidemia | Merck Sharp & Dohme LLC | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK0354 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00337415 ↗ |